Pharmaceutical

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Market capitalisation increased by a total of 2.3% from $3.49tn in Q1 2023 to $3.56tn in Q2 2023, according to GlobalData.

Sep 15, 2023 - 20:00
Market cap rebound by top 20 biopharmaceutical companies in Q2 2023
Market capitalisation increased by a total of 2.3% from $3.49tn in Q1 2023 to $3.56tn in Q2 2023, according to GlobalData.
Read the original article

Tags:

Previous Article

Cure Genetics and Frametact seek gene cures for neurological ailments

Next Article

Generate:Biomedicines secures $273m to advance therapeutic portfolio 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Treatment options for Crohn’s disease expand after Rinvoq approval

Treatment options for Crohn’s disease expand after Rinv...

May 20, 2023

Pierre Fabre announces another partnership to expand oncology R&D

Pierre Fabre announces another partnership to expand on...

Sep 25, 2023

How big data M&A performed in the pharmaceutical indust...

Jul 31, 2023